Pravin U. Dugel, M.D.

Pravin U. Dugel, M.D.

Executive Chair, President and Chief Executive OfficeratOcular Therapeutix· In proxies 2023–2025

Pay in FY2025+94% from the year before · Ocular Therapeutix stock +42.2% the same year

Pravin U. Dugel, M.D. was paid $35.9M in FY2025 (Dec), up 94%. Ocular Therapeutix stock rose 42.2% that year.

Pay$100 in the stock at the end of FY23 → $272
Pay is from the Summary Compensation Table of each Ocular Therapeutix proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Ocular TherapeutixPublic company · 3 yr
    • Executive Chair, President and Chief Executive Officer2023 – Present · 3 yrStock in role +176%
  2. Aerpio Pharmaceuticals, Inc.Public company · 9 yr
    • Director2017 – Present · 9 yrNo stock prices for these years
  3. Aadi Bioscience, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Oculis Holding AGPublic company · 4 yr
    • Director2020 – 2024 · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?